Mucocutaneous Adverse Events Associated With Oral Sirolimus for the Treatment of Vascular Anomalies

This case series examines the clinical spectrum and frequency of mucocutaneous adverse events related to oral sirolimus in populations with vascular anomalies.

Automated summary

This case series investigates the clinical spectrum and frequency of mucocutaneous adverse events related to oral sirolimus in populations with vascular anomalies. The study found a wide range of mucocutaneous adverse reactions caused by oral sirolimus in patients with vascular anomalies, with a relatively high frequency.